NABP e-News January 24, 2007
Medicine Shoppe International Agrees in Principle to Seek DMEPOS Accreditation from NABP
Medicine Shoppe International, Inc has agreed in principle to seek NABP accreditation for its pharmacies nationwide that supply durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). Medicine Shoppe International, a subsidiary of Cardinal Health Inc, has nearly 1,000 Medicine Shoppe® Pharmacies in the United States and more than 250 pharmacies in six other countries. Medicine Shoppe Pharmacies fill approximately 47 million prescriptions per year, making Medicine Shoppe International the largest franchisor of independent community pharmacies in the US, and one of the top three franchises in the health care industry.
Application for DMEPOS Pharmacy Accreditation Now Available Online
Pharmacies seeking accreditation to demonstrate their compliance with new quality standards for durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) can now apply online. NABP offers accreditation for licensed pharmacies that distribute certain DMEPOS products and services to Medicare patients and that seek reimbursement from Medicare Part B.
Henry Schein Becomes First Wholesaler to Have Entire Distribution System VAWD-Accredited
Henry Schein, Inc has become the first wholesale drug distributor in the nation to have its entire distribution system accredited through NABP’s Verified-Accredited Wholesale Distributors® (VAWD®) program. A worldwide distributor of health care products to office-based practitioners, Henry Schein received accreditation for its facilities in Indianapolis, IN; Jacksonville, FL; Denver, PA; Grapevine, TX; and Sparks, NV, as well as two of its subsidiaries. Although Henry Schein initially sought VAWD accreditation due to Indiana’s statutory requirement to become accredited, the company exceeded the Indiana requirement and obtained accreditation for its facilities outside that state.
Canadian Pharmacist and Patients' Groups Call for Ban on Drug Exports
Canadian pharmacist and patients’ groups have called on the Canadian government to ban the export, both bulk and retail, of prescription drugs. In Washington, lawmakers plan to move ahead with legislation to allow prescription drug imports from Canada as a way to address the high cost of prescription drugs in the United States. In an open letter to Canadian Minister of Health Tony Clement, pharmacist groups including the Canadian Pharmacists Association, Ontario Pharmacists’ Association, Best Medicines Coalition, and the Canadian Association for Pharmacy Distribution Management express concern that this legislation would create a shortage of prescription drugs for Canada’s own citizens.